Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsStridespharmascience

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Manappuram Finance, Strides Shasun: Sandeep Wagle

      Sandeep Wagle of powermywealth.com recommends buying Manappuram Finance and Strides Shasun.

    • These 10 pharma stocks’ PE trade at a discount of over 20% to 5-year average

      Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter

    • Market regains momentum after last week's 3.5% fall; top 4 stocks can give up to 50% returns

      The stocks include Hindalco Industries, CESC, TVS Motor Company and Strides Shasun which were come out with their June quarter earnings, which were mix bagged but broking house Motilal Oswal is expecting up to 50 percent return from these companies.

    • Buy Havells India, Vedanta: Sandeep Wagle

      Sandeep Wagle of powermywealth.com recommends buying Havells India and Vedanta.

    • Bull's Eye: Buy PNB, Titan, Cadila Health, Kajaria Ceramics, Havells, KRBL

      Jay Thakkar of Anand Rathi Securities advises buying Kajaria Ceramics with a and target of Rs 706.

    • Nifty likely to close above 10,000 in July series; 5 stocks which can give up to 14% return

      There has been aggressive put writing in near strikes with 9900 strike holds the maximum put open interest indicating strong support zone.

    • Key resistance for Nifty at 9969; 4 stocks to buy today: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, the next logical technical target for the Nifty is at 9969. The crucial support for the Index is at 9792-9720 and the resistance is at 9969 while Bank Nifty has support at 24100 and resistance at 24300-24400.

    • Bull's Eye: Buy Titan, Cummins, Delta Corp, Just Dial, SREI Infra, Strides Shasun

      Ashish Kyal of Waves Strategy Advisors is of the view that oen may buy Bajaj Finserv with a target of Rs 5190.

    • Bull's Eye: Buy Hindalco, Capital First, Cholamandalam, Voltas, PNB Housing

      Vishvesh Chauhan of Monarch Networth Capital advises buying Capital First with a target of Rs 790.

    • Buy, Sell, Hold: What stocks and sectors are on analysts' radar today?

      GAIL, Reliance and Reliance, among others, are being tracked by investors' radar.

    • Resistance for Bank Nifty at 23400; Hero Moto, JSPL bullish plays: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Nifty has support at 9430-9400 and resistance at 9600 while Bank Nifty has support at 22800 and resistance at 23400.

    • Sell Aurobindo Pharma, Strides Shasun may slip 5-6%: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com suggests selling Aurobindo Pharma and feels that Strides Shasun may slip 5-6 percent.

    • Buy SREI Infra, Escorts, Indiabulls Real Estate; sell Biocon: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy SREI Infrastructure Finance, Escorts and Indiabulls Real Estate and can sell Biocon and Strides Shasun.

    • Buy Power Grid Corporation; sell Strides Shasun: Mitessh Thakkar

      Mitessh Thakkar of mitesshthakkar.com advises buying Power Grid Corporation.

    • Buy Reliance Capital, Jubilant Foodworks, Sun TV; sell Strides Shasun, Idea Cellular: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying Reliance Capital, Jubilant Foodworks and Sun TV and advises selling Strides Shasun and Idea Cellular.

    • Buy ICICI Bank, PTC India, Greaves Cotton, Kalpataru Power; sell Strides Shasun: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests buying ICICI Bank, PTC India, Greaves Cotton and Kalpataru Power and advises selling Strides Shasun.

    • Sell Strides Shasun, Aurobindo Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends selling Strides Shasun and Aurobindo Pharma.

    • Buy Century Textiles and Industries, DHFL; sell Strides Shasun, Tata Comm, Amara Raja Batteries: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying Century Textiles and Industries and DHFL and advises selling Strides Shasun, Tata Comm and Amara Raja Batteries.

    • Buy, Sell, Hold: These 6 stocks would be in focus today

    • Oil India can climb to Rs 343, Strides Shasun Rs 1185: Gaba

      Prakash Gaba of prakashgaba.com is of the view that Oil India can climb to Rs 343 while Strides Shasun may hit Rs 1185.

    • Buy Sintex Industries, Strides Shasun: Sandeep Wagle

      Sandeep Wagle of powermywealth.com recommends buying Sintex Industries and Strides Shasun.

    • Invest in private sector banks for long-term, says Dipan Mehta

      In an interview to CNBC-TV18, Dipan Mehta, Member of BSE & NSE shared his readings and outlook on specific stocks and sector.

    • Strides Shasun a buying opportunity, ROE to clock 20%: Centrum

      Kunj Bansal of Centrum Wealth Management is of the view that Strides Shasun from the pharma space offers a very good buying opportunity with returm on equity likely to move to 20 percent.

    • Here are Prakash Diwan's top trading ideas

      In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Prakash Diwan of Altamount Capital Management shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy, sell, hold: 7 stocks to watch out for your portfolio

      Morgan Stanley is underweight on the stock, with a target price at Rs 1,372. Key positive surprise was better-than-expected realisation but better realisation was offset by higher per tonne cost, the research firm says.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347